NA85
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
03/17/2026
Back to search
Official data from USPTO
GEOMX
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: US
Quick snapshot
GEOMX
ST13
US500000087982200Class
1, 9, 10, 42
Filing
87982200
Registration
5945133
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
40
Latest update
03/18/2026
Classification
Registered
Trademark type
Word
Nice classes
1, 9, 10, 42
Filing date
05/09/2018
Registration date
12/24/2019
Expiration date
-
Recommended action
Perform a full collision analysis and validate classes before any filing or trademark investment.
Next step
These are the details of the registration process. Even so, constant monitoring is what ensures peace of mind that your main asset remains protected.
Complete case details
Structured fields from the responsible authority and the official record.
Status date
03/17/2026
Last transaction
03/18/2026
Responsible office
United States Patent and Trademark Office
Status code
702
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
09/03/2019
First use in commerce
09/03/2019
Drawing code
4
Owner type
03
Owner location
BILLERICA, MA, US
Examiner
MILLER, JUSTIN T
Current location
Historical data usage
Holders and representatives
Holders
BRUKER SPATIAL BIOLOGY, INC.
NanoString Technologies, Inc.
Representatives
Alyssa Worsham WILSON SONSINI GOODRICH & ROSATI
Technical classification
Nice Classes
Class 1Class 9Class 10Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 1
reagents and instruments for scientificresearch or non-medical or veterinary diagnostic use in the fields of pathologyimmunohistochemistryin situ-hybridizationproteomicsRNA transcriptionRNA translationgene expression profiling and nucleic acid sequencing; diagnostic reagents for scientific or research use in the fields of cancerneurology and infectious disease; reagents for scientificresearch or non-medical or veterinary diagnostic use relating to molecular identification and digital quantification; reagents for scientificresearch or non-medical or veterinary diagnostic use containing antibodies and nucleic acids; reagent kits comprising primarily reagents for scientificresearch or non-medical or veterinary diagnostic use in the fields of cancerneurology and infectious disease; reagents for immuno-histochemistry detection and in situ-hybridization detection for scientificresearch or non-medical or veterinary diagnostic use; test kits for scientificresearch or non-medical or veterinary diagnostic use comprising reagentsslidessolid matrix materialsmicrofluidic devices and support documentationinstructional manualstherefor; test kits comprising reagents for scientificresearch or non-medical or veterinary diagnostic use relating to molecular identification and digital quantification; reagents for in vitro use in clinical chemistry and molecular biology; reagents for clinical or medical laboratory usereagents for pathologyimmunohistochemistryin situ-hybridizationproteomicsRNA transcriptionRNA translationgene expression profilingnucleic acid sequencingclinicaloncologyneurologyinfectious disease diagnostics; multiparameter quantitative detection and analysis products and technology for research and diagnostics for a variety of uses in the health care and other life science sectorsreagents for scientific or medical research usediagnostic preparations and reagents for scientific or research usespathologyimmunohistochemistryin situ-hybridizationproteomicsRNA transcriptionRNA translationgene expression profiling and nucleic acid sequencing; test kitsconsisting of chemical preparations for scientific purposesin particular for the detectiondiagnosisprogress monitoring and progress prediction of diseasesincluding inflammationsinfectionsdisorders of the central nervous systemscardiovascularneurologicalendocrineautoimmune and genetic disorders and cancers
Class 9
automated apparatus in the nature of automated laboratory equipment and computer systems comprised of computer hardware and software for detection and analysis of biomolecules for scientific use; automated apparatus in the nature of automated laboratory equipment and computer systems comprised of computer hardware and software for scientific researchfor detectingcollecting and processing optical signals and imagesinto data for use in the analysis of biomolecules in connection with scientific or medical research; automated apparatus in the nature of automated laboratory equipment in the nature of digital imagersdigital displaysmicroscopesroboticsfluidic stations and computer systems for staining and/or visualization of tissue or cell based samples for diagnostic or scientific use; automated apparatus in the nature of automated laboratory equipment in the nature of digital imagersdigital displaysmicroscopesrobotics and computer systems for digitizing images of biological tissue for use in connection with pathology; automated apparatus in the nature of automated laboratory equipment in the nature of digital imagersdigital displaysmicroscopesrobotics and computer systems for capturing digital images of microscope slides of biological tissuestorage of digitized microscope slide images in a data storage areadisplay of digitized microscope slide images; automated apparatus in the nature of automated laboratory equipment in the nature of digital imagersdigital displaysmicroscopesroboticsfluidic stations and computer systems comprised of computer hardware and software for detection and analysis ofpathologygene expressionRNA transcriptionRNA translation and nucleic acid sequencing; computer hardware and software to enable pathologists to diagnose disease; computer hardware and software for the electronic scanning of clinical pathology slides; computer hardware and software for pathologists to render and report diagnoses and results of scientific research; computer hardware and software for scientific or research usespathologyimmunohistochemistryin situ-hybridizationproteomicsRNA transcription and microRNA expression profiling and nucleic acid sequencing; computer hardware and software for digitizingprocessing and storing images of biological tissues and cells; computer hardware and software for analyzing the results of tissues and cell based samples obtained through operation of tissue and cell sample staining and visualization apparatus; computer hardware and software for identifying and diagnosing cancer and other diseases and processing digital images; computer hardware and software for viewinganalyzingmanagingreportingarchiving digital images; laboratory equipment for sample preparationmixinghybridizationincubationwashinglocation and imagingrobotic equipmentfluid mixerspumpsvalvescontainersreagent holderssample containers and microfluidic devicesoptical devicesscanning microscopesfluorescent microscopesdigital micromirror deviceselectromagnetic sensors and replacement parts therefor in the fields of scientific research; computer systemssoftware and data files to acquireanalyzemanage and report biological information
Class 10
clinical and medical diagnostic instrumentshistopathology instruments and nucleic acid sequencers; clinical and medical diagnostic instruments for analysis of tissue and/or cell based samplesall for medical purposes; clinical and medical diagnostic instruments for performing immunohistochemistry and in situ-hybridization staining reactionshistological and pathological staining and image processing and analysis; histopathology instruments for clinical purposes; clinical and medical diagnostic instruments for immunohistochemistry and in situ-hybridization analyses; clinical and medical diagnostic instruments for the electronic scanning of clinical pathology slidesprocessing and storing images of biological tissues and cells and digitizingprocessing and storing images of biological tissues and cells
Class 42
research and product development services for others in the field of biotechnology; medical and scientific research services for others in the fields of pathologyimmunohistochemistryin situ-hybridizationproteomicsRNA transcriptionRNA translationgene expression profiling and nucleic acid sequencing; medical and scientific research in the field of cancer treatment and diagnosis; medical and scientific research services for others in the field of infectious disease; medical and scientific research services for others in the field of neurology; medical and scientific research services for othersresearch and design in the field of testinganalyzing and examining biological samplesmedical samplescell samples; providing laboratory research services for others in the field of gene expression and genetic data mining; research and development services for others for acquiringanalyzingmanaging biological and genetic information in the fields of diagnostic reagentsforensicsmedicinegeneticsenvironment; researchdesigndevelopment services for others in the fields of diagnostic reagentscompounds and devicesmeasuring apparatus for use in product research and developmentseparation and purification processes
Publications
History of USPTO decisions and trademark events.
40 publications found
C15A
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
03/17/2026
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
03/16/2026
E815
TEAS SECTION 8 & 15 RECEIVED
12/11/2025
REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
12/24/2024
ASGN
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
07/04/2024
R.PR
REGISTERED-PRINCIPAL REGISTER
12/24/2019
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
11/21/2019
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
11/20/2019
SUPC
STATEMENT OF USE PROCESSING COMPLETE
10/28/2019
DPCC
DIVISIONAL PROCESSING COMPLETE
10/28/2019
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
10/25/2019
IUAF
USE AMENDMENT FILED
10/23/2019
DRRR
DIVISIONAL REQUEST RECEIVED
10/23/2019
ERTD
TEAS REQUEST TO DIVIDE RECEIVED
10/23/2019
EISU
TEAS STATEMENT OF USE RECEIVED
10/23/2019
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
10/03/2019
EX1G
SOU EXTENSION 1 GRANTED
10/02/2019
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
10/02/2019
NREV
NOTICE OF REVIVAL - E-MAILED
08/15/2019
TPEX
SOU EXTENSION RECEIVED WITH TEAS PETITION
08/15/2019
PETG
PETITION TO REVIVE-GRANTED
08/15/2019
PROA
TEAS PETITION TO REVIVE RECEIVED
08/15/2019
EXT1
SOU EXTENSION 1 FILED
08/05/2019
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
02/05/2019
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
12/11/2018
PUBO
PUBLISHED FOR OPPOSITION
12/11/2018
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
11/21/2018
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
11/02/2018
ALIE
ASSIGNED TO LIE
11/02/2018
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
10/18/2018
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
10/15/2018
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
10/14/2018
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
10/14/2018
GPRN
NOTIFICATION OF PRIORITY ACTION E-MAILED
08/31/2018
GPRA
PRIORITY ACTION E-MAILED
08/31/2018
CPRA
PRIORITY ACTION WRITTEN
08/31/2018
DOCK
ASSIGNED TO EXAMINER
08/30/2018
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
05/18/2018
NWAP
NEW APPLICATION ENTERED
05/12/2018
Continuous trademark protection
Get notified about every new filing that threatens GEOMX or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.